S. Antimisiaris

发表

Targeted si-RNA with liposomes and exosomes (extracellular vesicles): How to unlock the potential.

S. Antimisiaris, S. Mourtas, K. Papadia, 2017, International journal of pharmaceutics.

S. Antimisiaris, P. Kallinteri, D. Fatouros, 2010 .

Assessment of Atmospheric‐Pressure Guided Streamer (Plasma Bullet) Influence on Liposomes with Different Composition and Physicochemical Properties

S. Antimisiaris, K. Gazeli, P. Svarnas, 2015 .

Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.

P. Couraud, S. Antimisiaris, I. Romero, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Liposomes as vaccine carriers. Incorporation of soluble and particulate antigens in giant vesicles.

S. Antimisiaris, G. Gregoriadis, P. Jayasekera, 1993, Journal of immunological methods.

Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles.

S. Antimisiaris, A. Fadda, M. Manca, 2008, Colloids and surfaces. B, Biointerfaces.

Mobility of zero valent iron nanoparticles and liposomes in porous media

C. Tsakiroglou, C. Aggelopoulos, S. Antimisiaris, 2016 .

The effect of pH on the electrophoretic behaviour of a new class of liposomes: arsonoliposomes.

S. Antimisiaris, D. Fatouros, P. V. Ioannou, 2005, International journal of pharmaceutics.

Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles.

S. Antimisiaris, P. Frederik, D. Fatouros, 2006, Chemistry and physics of lipids.

Liposomes containing cyclodextrins or meglumine to solubilize and improve the bioavailability of poorly soluble drugs

S. Antimisiaris, M. Longhi, C. Aloisio, 2017 .

Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: comparison of membrane integrity and drug release.

S. Antimisiaris, D. Fatouros, K. Hatzidimitriou, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Arsonoliposomes: Effect of Lipid Composition on Their Stability and Morphology

S. Antimisiaris, P. Frederik, P. V. Ioannou, 2005, Journal of liposome research.

Release of liposome-encapsulated calcein from liposome entrapping gelatin-carboxymethylcellulose films: a presentation of different possibilities.

S. Antimisiaris, M. Popa, C. Peptu, 2008, Journal of nanoscience and nanotechnology.

Engineered versus hybrid cellular vesicles as efficient drug delivery systems: a comparative study with brain targeted vesicles

M. Kannavou, S. Antimisiaris, G. Stathopoulos, 2021, Drug Delivery and Translational Research.

Liposome-coated metal stents: an in vitro evaluation of controlled-release modality in the ureter.

S. Antimisiaris, D. Fatouros, C. Kalogeropoulou, 2000, Journal of endourology.

Overcoming barriers by local drug delivery with liposomes.

M. Kannavou, S. Antimisiaris, S. Mourtas, 2021, Advanced drug delivery reviews.

Atmospheric-pressure guided streamers for liposomal membrane disruption

S. Antimisiaris, S. Aleiferis, K. Gazeli, 2012 .

In Vitro Anti-Biofilm Activity of Bacteriophage K (ATCC 19685-B1) and Daptomycin against Staphylococci

S. Antimisiaris, E. Sazakli, M. Leotsinidis, 2021, Microorganisms.

Interactions of PC/Chol and PS/Chol Liposomes with Human Cells in Vitro

E. Papadimitriou, S. Antimisiaris, 2000, Journal of drug targeting.

Arsonoliposomes for the Potential Treatment of Medulloblastoma

S. Antimisiaris, P. Kallinteri, M. E. Favretto, 2009, Pharmaceutical Research.

Folic Acid—Targeted Doxorubicin Drug Delivery System for Triple-Negative Breast Cancer Treatment

S. Antimisiaris, S. Mourtas, E. Lamprou, 2020, Proceedings.

Hemocompatibility of amyloid and/or brain targeted liposomes.

S. Antimisiaris, S. Mourtas, Y. Missirlis, 2019, Future medicinal chemistry.

Capability of arsonolipids to transport divalent cations: a Pressman cell study.

S. Antimisiaris, O. Gortzi, P. V. Ioannou, 2001, Chemistry and physics of lipids.

Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques.

S. Antimisiaris, S. Mourtas, R. Loddo, 2011, AIDS research and human retroviruses.

Anti-Aβ-MAb and dually decorated nanoliposomes: effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells.

S. Antimisiaris, K. Papadia, O. Flores, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Dexamethasone Incorporating Liposomes: Effect of Lipid Composition on Drug Trapping Efficiency and Vesicle Stability

S. Antimisiaris, S. Mourtas, V. Tsotas, 2007, Drug delivery.

Multifunctional doxorubicin‐loaded magnetoliposomes with active and magnetic targeting properties

S. Antimisiaris, S. Mourtas, K. Papadia, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Preparation, Physicochemical Properties, and In Vitro Toxicity towards Cancer Cells of Novel Types of Arsonoliposomes

S. Antimisiaris, S. Mourtas, Paraskevi Zagana, 2020, Pharmaceutics.

Arsonoliposomes: preparation and physicochemical characterization.

S. Antimisiaris, P. V. Ioannou, 2010, Methods in molecular biology.

Arsonoliposomes for drug delivery applications

S. Antimisiaris, 2009 .

Does the lipid membrane composition of arsonoliposomes affect their anticancer activity? A cell culture study.

S. Antimisiaris, P. V. Ioannou, E. Giannopoulou, 2009, Molecular nutrition & food research.

In vivo distribution of arsonoliposomes: effect of vesicle lipid composition.

S. Antimisiaris, P. V. Ioannou, P. Klepetsanis, 2008, International journal of pharmaceutics.

Trypanocidal activity of arsonoliposomes: effect of vesicle lipid composition.

S. Antimisiaris, P. Loiseau, P. V. Ioannou, 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Arsonoliposomes for drug delivery

S. Antimisiaris, 2007 .

Liposomal Entrapment or Chemical Modification of Relaxin2 for Prolongation of Its Stability and Biological Activity

S. Antimisiaris, S. Mourtas, P. Klepetsanis, 2022, Biomolecules.

Synthesis of Novel Arsonolipids and Development of Novel Arsonoliposome Types

Golfo G. Kordopati, S. Antimisiaris, S. Mourtas, 2022, Pharmaceutics.

Moxifloxacin Liposomes: Effect of Liposome Preparation Method on Physicochemical Properties and Antimicrobial Activity against Staphylococcus epidermidis

S. Antimisiaris, S. Mourtas, M. Stuart, 2022, Pharmaceutics.

Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection

S. Antimisiaris, K. Papadia, G. Stathopoulos, 2019, International journal of nanomedicine.

Covalent immobilization of liposomes on plasma functionalized metallic surfaces.

E. Farsari, S. Antimisiaris, S. Mourtas, 2011, Colloids and surfaces. B, Biointerfaces.

Haemolytic activity of liposomes: effect of vesicle size, lipid concentration and polyethylene glycol-lipid or arsonolipid incorporation.

S. Antimisiaris, S. Mourtas, Y. Missirlis, 2009, Journal of biomedical nanotechnology.

Physical stability of sonicated arsonoliposomes: effect of calcium ions.

S. Antimisiaris, P. Frederik, D. Fatouros, 2005, Journal of pharmaceutical sciences.

In‐vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in‐vivo distribution in BALB/c mice

S. Antimisiaris, P. Loiseau, P. V. Ioannou, 2003, The Journal of pharmacy and pharmacology.

Liposomes Decorated with 2-(4'-Aminophenyl)benzothiazole Effectively Inhibit Aβ1-42 Fibril Formation and Exhibit in Vitro Brain-Targeting Potential.

M. Kannavou, S. Antimisiaris, S. Mourtas, 2020, Biomacromolecules.

Stability of Protein-Encapsulating DRV Liposomes After Freeze-Drying: A Study with BSA and t-PA

M. Tsilimbaris, S. Antimisiaris, S. Mourtas, 2006, Journal of liposome research.

UPTAKE OF LIPOSOMES WHICH INCORPORATE A GLYCOPEPTIDE FRACTION OF ASIALOFETUIN BY HepG2 CELLS

E. Papadimitriou, S. Antimisiaris, P. Kallinteri, 2001, Journal of liposome research.

Haemocompatibility improvement of metallic surfaces by covalent immobilization of heparin-liposomes.

S. Antimisiaris, S. Mourtas, E. Sardella, 2012, International journal of pharmaceutics.

Multifunctional LUV liposomes decorated for BBB and amyloid targeting ‐ B. In vivo brain targeting potential in wild‐type and APP/PS1 mice

S. Antimisiaris, S. Mourtas, K. Papadia, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Preparation of DRV Liposomes.

S. Antimisiaris, 2017, Methods in molecular biology.

Characterization, Stability and In - Vivo Distribution of Asialofetuin Glycopeptide Incorporating DSPC/CHOL Liposomes Prepared by Mild Cholate Incubation

S. Antimisiaris, P. Kallinteri, K. Hwang, 2001, Journal of drug targeting.

Synergistic effect of cold atmospheric pressure plasma and free or liposomal doxorubicin on melanoma cells

S. Antimisiaris, M. Rodi, A. Mouzaki, 2021, Scientific Reports.

Development of growth factor-incorporating liposomes for integration into scaffolds as a method to improve tissue regeneration.

S. Antimisiaris, A. Marazioti, E. Natsaridis, 2021, The International journal of developmental biology.

Quantification of BNN27, a novel neuroprotective 17‐spiroepoxy dehydroepiandrosterone derivative in the blood and retina of rodents, after single intraperitoneal administration

M. Tsilimbaris, M. Tzatzarakis, S. Antimisiaris, 2021, Pharmacology research & perspectives.

Protection of dopamine towards autoxidation reaction by encapsulation into non-coated- or chitosan- or thiolated chitosan-coated-liposomes.

A. Trapani, D. Mandracchia, S. Antimisiaris, 2018, Colloids and surfaces. B, Biointerfaces.

Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease.

Charles Duyckaerts, Spyridon Mourtas, C. Duyckaerts, 2014, European journal of medicinal chemistry.

Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof‐of‐concept

M. Salmona, S. Antimisiaris, S. Mourtas, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

How do the physicochemical properties of nanoliposomes affect their interactions with the hCMEC/D3 cellular model of the BBB?

S. Antimisiaris, K. Papadia, E. Markoutsa, 2016, International journal of pharmaceutics.

Potential of nanoliposomes for the therapy and/or diagnosis of Alzheimer’s disease: recent progress

S. Antimisiaris, 2014 .

Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus macaques with RT-SHIV.

S. Antimisiaris, S. Mourtas, R. Loddo, 2010, Virology.

Preparation of Benzothiazolyl-Decorated Nanoliposomes

S. Antimisiaris, S. Mourtas, P. Klepetsanis, 2019, Molecules.

Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide.

M. Gobbi, F. Nicotra, M. Salmona, 2011, Biomaterials.

Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

S. Antimisiaris, A. Alexander, S. Saraf, 2018, Journal of controlled release : official journal of the Controlled Release Society.

In vivo distribution of arsenic after i.p. injection of arsonoliposomes in balb-c mice.

S. Antimisiaris, V. Zachariou, P. Klepetsanis, 2005, International journal of pharmaceutics.

Arsonoliposomes: effect of arsonolipid acyl chain length and vesicle composition on their toxicity towards cancer and normal cells in culture.

E. Papadimitriou, S. Antimisiaris, O. Gortzi, 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Preparation and properties of arsonolipid containing liposomes.

S. Antimisiaris, M. Stuart, D. Fatouros, 2001, Chemistry and physics of lipids.

Recent advances on anti-HIV vaginal delivery systems development.

S. Antimisiaris, S. Mourtas, 2015, Advanced drug delivery reviews.

Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region

Ajazuddin, S. Antimisiaris, Shyh-Dar Li, 2018, Expert opinion on drug delivery.

Liposomes for drug delivery to the lungs by nebulization.

S. Antimisiaris, S. Mourtas, A. Fadda, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

The effect of added liposomes on the rheological properties of a hydrogel: a systematic study.

C. Tsakiroglou, M. Theodoropoulou, S. Antimisiaris, 2008, Journal of colloid and interface science.

Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.

C. Tsakiroglou, S. Antimisiaris, S. Mourtas, 2007, Colloids and surfaces. B, Biointerfaces.

Dexamethasone incorporating liposomes: an in vitro study of their applicability as a slow releasing delivery system of dexamethasone from covered metallic stents.

D. Karnabatidis, S. Antimisiaris, P. Kallinteri, 2002, Biomaterials.

Elastic vesicles for transdermal drug delivery of hydrophilic drugs: a comparison of important physicochemical characteristics of different vesicle types.

S. Antimisiaris, A. Fahr, Vassiliki Ntimenou, 2012, Journal of biomedical nanotechnology.

Arsenic Trioxide Liposomes: Encapsulation Efficiency and In Vitro Stability

S. Antimisiaris, P. Kallinteri, D. Fatouros, 2004, Journal of liposome research.

Thermal behavior of novel non-sonicated arsonolipid-containing liposomes.

S. Koutsopoulos, S. Antimisiaris, D. Fatouros, 2006, Biophysical chemistry.

PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.

S. Antimisiaris, S. Mourtas, A. Fadda, 2008, Colloids and surfaces. B, Biointerfaces.

Increasing the stability of curcumin in serum with liposomes or hybrid drug-in-cyclodextrin-in-liposome systems: a comparative study.

S. Antimisiaris, S. Mourtas, P. Klepetsanis, 2014, International journal of pharmaceutics.

A Novel Design of a PVA Electrospun Nanofibrous Scaffold Incorporating Liposomes as Drug Delivery Carriers for Tissue Engineering

D. Mavrilas, S. Antimisiaris, D. Markatos, 2018 .

Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition.

S. Antimisiaris, P. Kallinteri, D. Fatouros, 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Nanobiosystems for Antimicrobial Drug-Resistant Infections

S. Antimisiaris, I. Spiliopoulou, N. Giormezis, 2021, Nanomaterials.

Pharmacokinetics of cephalexin in sea bream, Sparus aurata (L.), after a single intraperitoneal injection

J. Iliopoulou-Georgudaki, P. Katharios, M. Maffia, 2004 .

Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease.

C. Duyckaerts, B. Delatour, S. Antimisiaris, 2013, Nanomedicine : nanotechnology, biology, and medicine.

Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide.

M. Masserini, F. Nicotra, D. Allsop, 2011, Nanomedicine : nanotechnology, biology, and medicine.

Drug Binding and Solubility in Milk

M. Koupparis, S. Antimisiaris, P. Macheras, 1990, Pharmaceutical Research.

Effect of temperature and fat content on the solubility of hydrochlorothiazide and chlorothiazide in milk.

P E Macheras, M. Koupparis, S. Antimisiaris, 1989, Journal of pharmaceutical sciences.

Effect of temperature and fat content on the binding of hydrochlorothiazide and chlorothiazide to milk.

P E Macheras, M. Koupparis, S. Antimisiaris, 1988, Journal of pharmaceutical sciences.

Solubility of drugs in the presence of gelatin: effect of drug lipophilicity and degree of ionization.

S. Antimisiaris, P. Kallinteri, 2001, International journal of pharmaceutics.

Arsonoliposomes: novel nanosized arsenic-containing vesicles for drug delivery.

S. Antimisiaris, D. Fatouros, P. V. Ioannou, 2006, Journal of nanoscience and nanotechnology.

Arsonoliposome interaction with thiols: effect of pegylation and arsonolipid content of arsonoliposomes on their integrity during incubation in glutathione.

S. Antimisiaris, P. V. Ioannou, Paraskevi Zagana, 2006, Journal of nanoscience and nanotechnology.

Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery

S. Antimisiaris, S. Mourtas, A. Marazioti, 2018, Pharmaceutics.

KRAS signaling in malignant pleural mesothelioma

M. Lindner, H. Papadaki, S. Antimisiaris, 2021, EMBO molecular medicine.

KRAS signalling in malignant pleural mesothelioma

M. Lindner, S. Antimisiaris, R. Hatz, 2020, bioRxiv.

Recent advancements in liposomes targeting strategies to cross blood‐brain barrier (BBB) for the treatment of Alzheimer's disease

Ajazuddin, S. Antimisiaris, S. Mourtas, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Simultaneous quantitative determination of diazepam and liposomes using differential pulse polarography

C. Kontoyannis, S. Antimisiaris, D. Douroumis, 1999 .

Dopamine-loaded lipid based nanocarriers for intranasal administration of the neurotransmitter: a comparative study.

A. Trapani, M. Conese, S. Antimisiaris, 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Complex hydrogel systems composed of polymers, liposomes, and cyclodextrins: implications of composition on rheological properties and aging.

C. Tsakiroglou, C. Aggelopoulos, S. Antimisiaris, 2009, Langmuir : the ACS journal of surfaces and colloids.

Arsonoliposomes, a Novel Class of Arsenic-Containing Liposomes: Effect of Palmitoyl-Arsonolipid-Containing Liposomes on the Viability of Cancer and Normal Cells in Culture

E. Papadimitriou, C. Kontoyannis, S. Antimisiaris, 2004, Pharmaceutical Research.

pH-responsive hydrogel/liposome soft nanocomposites for tuning drug release.

C. Tsitsilianis, S. Antimisiaris, S. Mourtas, 2011, Biomacromolecules.

LIPOSOMAL GELS FOR VAGINAL DELIVERY OF THE MICROBICIDE MC-1220: PREPARATION AND IN VIVO VAGINAL TOXICITY AND PHARMACOKINETICS

S. Antimisiaris, S. Mourtas, R. Storer, 2010 .

Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility.

S. Antimisiaris, Y. Missirlis, G. Koromila, 2006, Biomaterials.

Effect of amphiphilic drugs on the stability and zeta-potential of their liposome formulations: a study with prednisolone, diazepam, and griseofulvin.

Dimitrios G Fatouros, S. Antimisiaris, D. Fatouros, 2002, Journal of colloid and interface science.

Nanoparticles for Diagnosis and/or Treatment of Alzheimer's Disease

S. Antimisiaris, S. Mourtas, K. Papadia, 2014 .

Development and Comparative In Vitro and In Vivo Study of BNN27 Mucoadhesive Liposomes and Nanoemulsions for Nose-to-Brain Delivery

M. Kannavou, T. Katsila, S. Antimisiaris, 2023, Pharmaceutics.

Chitosan-coated liposomes for delivery to lungs by nebulisation.

S. Antimisiaris, A. Fadda, M. Manca, 2009, Colloids and surfaces. B, Biointerfaces.

Mutant KRAS promotes malignant pleural effusion formation

O. Eickelberg, S. Antimisiaris, K. Papadia, 2017, Nature Communications.

Effect of temperature and fat content on the binding of hydrochlorothiazide and chlorothiazide to milk

M. Koupparis, S. Antimisiaris, P. Macheras, 1988 .

Resveratrol loaded in cationic glucosylated liposomes to treat Staphylococcus epidermidis infections.

A. Ciogli, C. Bombelli, G. Mancini, 2022, Chemistry and physics of lipids.

The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.

M. Masserini, C. Duyckaerts, M. Gobbi, 2011, Biomaterials.

Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels.

S. Antimisiaris, S. Mourtas, Styliani Fotopoulou, 2008, Colloids and surfaces. B, Biointerfaces.

Cellular Vesicles: New Insights in Engineering Methods, Interaction with Cells and Potential for Brain Targeting

M. Kannavou, G. Panayotou, S. Antimisiaris, 2019, The Journal of Pharmacology and Experimental Therapeutics.

Medical Device Development for Children and Young People—Reviewing the Challenges and Opportunities

L. Marciani, F. Ernst, F. Bonifazi, 2021, Pharmaceutics.

Magnetoliposomes with high USPIO entrapping efficiency, stability and magnetic properties.

S. Antimisiaris, S. Mourtas, A. Skouras, 2011, Nanomedicine : nanotechnology, biology, and medicine.

Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid β1-42 peptide.

F. Nicotra, S. Antimisiaris, S. Mourtas, 2014, European journal of medicinal chemistry.

Stability and aggregation studies of non-sonicated arsonolipid-containing vesicles.

S. Antimisiaris, D. Fatouros, P. V. Ioannou, 2005, Cellular & molecular biology letters.

Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition.

Spyridon Mourtas, S. Antimisiaris, S. Mourtas, 2007, International journal of pharmaceutics.

Bioavailability And Pharmacokinetics Of A Synthetic DHEA Analog, A Novel Anti-apoptotic Agent, After IP Injection In Normal Rodents

M. Tsilimbaris, M. Tzatzarakis, S. Antimisiaris, 2012 .

Applications of Nanoparticles for Alzheimer’s Disease Diagnosis and/or Treatment

S. Antimisiaris, S. Mourtas, K. Papadia, 2015 .

Quantitative determination of the non-entrapped chlorothiazide in the presence of liposomes using differential pulse polarography.

C. Kontoyannis, S. Antimisiaris, D. Douroumis, 1999, Talanta.

A simplified method to attach antibodies on liposomes by biotin-streptavidin affinity for rapid and economical screening of targeted liposomes.

S. Antimisiaris, K. Papadia, E. Markoutsa, 2014, Journal of biomedical nanotechnology.

Comparison of Various Types of Ligand Decorated Nanoliposomes for their Ability to Inhibit Amyloid Aggregation and to Reverse Amyloid Cytotoxicity.

J. Pei, S. Antimisiaris, S. Mourtas, 2015, Current topics in medicinal chemistry.

Novel TNBC-Targeted DOX-Arsonoliposomes

S. Antimisiaris, S. Mourtas, Maria Mantzari, 2020, Proceedings.

Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.

P. Couraud, S. Antimisiaris, I. Romero, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide.

M. Masserini, F. Nicotra, D. Allsop, 2011, Nanomedicine : nanotechnology, biology, and medicine.

The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.

M. Masserini, C. Duyckaerts, M. Gobbi, 2011, Biomaterials.

Chitosan-coated liposomes for delivery to lungs by nebulisation.

S. Antimisiaris, A. Fadda, M. Manca, 2009, Colloids and surfaces. B, Biointerfaces.

Preparation of DRV liposomes.

S. Antimisiaris, 2010, Methods in molecular biology.

An in vitro model for exploring CR theophylline-milk fat interactions

Sophia G. Antimisiaris, Michael A. Koupparis, M. Koupparis, 1989 .